Home›Stock Screener›Gian Life Care

Gian Life Care Share Price Today | Stock Price & Gian Life Care Share Screener

GIANLIFE Healthcare Service Provider
Live Share Price BSE
₹4.54
▲ 0.01 (0.22%)
2026-10-16 00:00:00

As of October 16, 2026, the live Gian Life Care share price (BSE: GIANLIFE) is ₹4.54, up 0.22% from the previous close, with shares trading between ₹4.31 and ₹4.64 in today's trading session, and a 52-week range of ₹4.28–₹12.98. Check GIANLIFE price range for the annual price range and momentum. Use the Gian Life Care stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Gian Life Care opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Gian Life Care Market Cap ₹4.61 Cr.
GIANLIFE P/E Ratio (TTM) -4.73
Gian Life Care P/B Ratio 0.24
EPS (TTM) ₹-0.04
Dividend Yield -
Debt to Equity 0.28
GIANLIFE 52 Week High ₹12.98
Gian Life Care 52 Week Low ₹4.28
Operating Margin 21.00%
Profit Margin -
GIANLIFE Revenue (TTM) ₹1.00
EBITDA -
Net Income -
Total Assets ₹36.00
Total Equity ₹19.00

Gian Life Care Share Price Chart

Track the current stock price of Gian Life Care with an interactive chart. Analyse GIANLIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Gian Life Care stock quote in one place.

The quote of ₹4.54 sits between the 52-week low of ₹4.28 and the 52-week high of ₹12.98, and the latest session moved 0.22% from the previous close.

Gian Life Care Company Profile - Fundamental Screener

Screen Gian Life Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GIANLIFE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE063601012.

Company Details

Classification

Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E

Identifiers and Leadership

ISIN INE063601012

Gian Life Care Balance Sheet Screener

Screen GIANLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹36, up from ₹33 in 2024.

Latest statistics put total assets at ₹36 and shareholder funds at ₹19, with a leverage ratio of 0.28.

Item 2025 2024 2023 2022

Assets

Total Assets 36 33 28 23
Current Assets 0 0 0 0
Fixed Assets 4 5 5 4

Liabilities

Total Liabilities 0 0 0 0
Current Liabilities 4 3 2 2
Non-Current Liabilities 0 0 0 0

Shareholders' Equity

Total Equity 19 19 15 14
Share Capital 10 10 10 10
Reserves & Surplus 9 9 5 4

Gian Life Care Income Statement Screener - Profit & Revenue Analysis

Screen Gian Life Care income statement and profit fundamentals. Analyze GIANLIFE quarterly results. Gian Life Care reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Dec, revenue was ₹1 and net profit was ₹0, equal to earnings per unit of ₹0.10, at an operating margin of 21%.

In that period expenses were ₹1, interest cost ₹0 and tax ₹0. The next period listed, 2025-Sept, shows revenue of ₹1 and net profit of ₹-1.

Item 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun

Revenue and Expenses

Revenue 1 1 1 1 2 2 2 5 4 2 3 2 5 3 3
Expenses 1 1 1 1 1 2 2 2 2 2 2 2 3 2 3

Operating Costs and Margins

EBITDA 0 0 0 0 1 0 0 3 2 1 1 -1 2 1 0
Operating Profit % 21.00% -62.00% 16.00% -1.00% 30.00% 11.00% 11.00% 66.00% 58.00% 14.00% 21.00% -49.00% 45.00% 15.00% -4.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 -1 0 -1 0 0 0 3 2 0 0 -1 2 1 0
Tax 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0
Net Profit 0 -1 0 -1 0 0 0 2 2 0 0 -1 2 1 0
EPS 0.10 -0.50 0.05 -0.59 0.34 0.12 0.09 2.07 1.50 0.20 0.25 -0.92 1.80 0.44 0.00

Gian Life Care Cash Flow Screener - Liquidity Fundamentals

Screen GIANLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹0, and net cash flow was an inflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

Item 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 0 1 2 6
Investing Activities 0 0 -1 -4

Financing and Net Cash

Financing Activities 0 0 0 1
Net Cash Flow 1 0 1 2

Gian Life Care Shareholding Pattern Screener

See Gian Life Care shareholding pattern with promoter, FII, and DII holdings. Check Gian Life Care promoter holding and ownership changes for GIANLIFE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 30.17%, foreign institutions 0.00%, domestic institutions 0.00% and the public 53.47%, spread across 4,243 shareholders.

The shareholder count was 4,243 in 2026-Mar, compared with 4,382 in 2025-Mar.

Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept

Promoter Holding

Promoter Holding 30.17% 32.09% 32.09% 32.09% 32.09% 48.47% 32.82% 31.99%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00%
Public Holding 53.47% 57.72% 57.96% 54.15% 54.05% 40.36% 56.34% 56.62%
Other Holding 16.35% 10.17% 9.93% 13.75% 13.85% 11.18% 10.84% 11.39%
Shareholder Count 4,243 4,382 4,363 4,285 4,217 2,426 3,349 3,863

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Gian Life Care. Gian Life Care dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Gian Life Care.

Gian Life Care Stock Index Membership - Nifty & Sensex

See which indices include Gian Life Care stock. Check GIANLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Gian Life Care is not part of any tracked indices.
Only major market indices are tracked in our system.

Gian Life Care Market Events Screener - Corporate Actions

Get Gian Life Care corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Gian Life Care stock events that may affect GIANLIFE share price, along with derivatives, futures and options activity and sector gainers.

8 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated February 14, 2026, with a record date of February 14, 2026.

It is followed by Quarterly Result Announcement dated January 28, 2026 and Annual General Meeting dated September 30, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-02-14 2026-02-14 Quarterly Result Announcement NA -6.94%
2026-01-28 2026-01-28 Quarterly Result Announcement NA -3.09%
2025-09-30 2025-09-30 Annual General Meeting NA -4.49%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 0.72%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -9.72%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -1.58%
2024-09-30 2024-09-30 Annual General Meeting NA -4.18%
2022-03-29 2022-03-30 Bonus 6:5 1.30%

Gian Life Care Competitors Screener - Peer Stocks Comparison

Screen GIANLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 32,069 60.51 2,864 12.11% 510 46.79
Vijaya Diagnostic Centre 14,487 79.85 835 19.34% 173 40.37
Metropolis Healthcare 11,090 54.95 1,671 24.15% 191 38.01
Thyrocare Technologies 7,950 46.60 846 20.48% 163 32.74
Nephrocare Health Services 6,244 73.19 1,023 32.93% 77 30.08
Krsnaa Diagnostics 1,728 17.74 816 9.90% 101 41.73
Suraksha Diagnostic 1,637 45.94 314 22.55% 31 41.80
3B BlackBio DX 1,304 24.59 142 27.17% 61 51.78
One Global Service Provider 1,075 14.50 499 237.48% 70 50.02
Health X Platform 900 -34.71 1,378 17.65% -1 42.95

Gian Life Care Company Announcements - News & Reports Screener

Screen GIANLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated April 21, 2026.

The next most recent announcements are dated March 4, 2026 and February 14, 2026.

Date Update Actions
2026-04-21 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-04 Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Approval To Enter Into Hospital Lab Management Services With M/S. Brahma Hospital (HUF) -
2026-02-14 Outcome Of Board Meeting Held On Saturday February 14 2026 -
2026-02-14 Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 -
2026-02-09 Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended On 31St December 2025 -
2026-01-28 Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Half Year Ended 30Th September 2025 -
2026-01-28 Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday January 28 2026 -
2026-01-24 Board Meeting Intimation for Rescheduling Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 30Th September 2025 -
2026-01-21 Board Meeting Intimation for Rescheduling Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 30Th September 2025 -
2026-01-21 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-01-15 Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 30Th September 2025 And 31St December 2025 -
2025-10-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-10-06 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-10-04 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-10-04 Proceedings Of AGM -
2025-09-10 Reg. 34 (1) Annual Report. -
2025-09-10 Shareholders Meeting On September 30 2025 -
2025-09-02 Results For Quarter Ended June 30 2025 -
2025-09-02 Results For Financial Year 01/04/2024-31/03/2025 -
2025-09-02 Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 14 2025 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹4.54, within a 52-week range of ₹4.28 to ₹12.98. The P/E ratio is -4.73 and the P/B ratio is 0.24, with earnings per unit of ₹-0.04. Market capitalisation stands at ₹4.61 Cr. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 19, 2026. This page covers 4 balance sheet periods, 15 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.